Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil

Detalhes bibliográficos
Autor(a) principal: Oliveira, Maria I
Data de Publicação: 2002
Outros Autores: Curti, Suely P, Figueiredo, Cristina A, Afonso, Ana MS, Theobaldo, Márcia, Azevedo, Raymundo S, Durigon, Edison L
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista de Saúde Pública
DOI: 10.1590/S0034-89102002000200006
Texto Completo: https://www.revistas.usp.br/rsp/article/view/25317
Resumo: OBJECTIVE: The clinical differential diagnosis of rash due to viral infections is often difficult, and misdiagnosis is not rare, especially after the introduction of measles and rubella vaccination. A study to determine the etiological diagnosis of exanthema was carried out in a group of children after measles vaccination. METHODS: Sera collected from children with rash who received measles vaccine were reported in 1999. They were analyzed for IgM antibodies against measles virus, rubella virus, human parvovirus B19 (HPV B19) using ELISA commercial techniques, and human herpes virus 6 (HHV 6) using immunofluorescence commercial technique. Viremia for each of those viruses was tested using a polimerase chain reaction (PCR). RESULTS: A total of 17 cases of children with exanthema after measles immunization were reported in 1999. The children, aged 9 to 12 months (median 10 months), had a blood sample taken for laboratory analysis. The time between vaccination and the first rash signs varied from 1 to 60 days. The serological results of those 17 children suspected of measles or rubella infection showed the following etiological diagnosis: 17.6% (3 in 17) HPV B19 infection; 76.5% (13 in 17) HHV 6 infection; 5.9% (1 in 17) rash due to measles vaccine. CONCLUSIONS: The study data indicate that infection due to HPV B19 or HHV 6 can be misdiagnosed as exanthema due to measles vaccination. Therefore, it is important to better characterize the etiology of rash in order to avoid attributing it incorrectly to measles vaccine.
id USP-23_049ff52975693148eedd7b56d3edb235
oai_identifier_str oai:revistas.usp.br:article/25317
network_acronym_str USP-23
network_name_str Revista de Saúde Pública
spelling Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil Exantema após vacinação do sarampo: análise laboratorial de casos notificados em São Paulo Vacinação do sarampoParvovírus humano B19Herpes vírus humano 6ExantemaRubéolaSarampoMeasles vaccinationHuman parvovirus B19Human herpes virus 6ExanthemaRubellaMeasles OBJECTIVE: The clinical differential diagnosis of rash due to viral infections is often difficult, and misdiagnosis is not rare, especially after the introduction of measles and rubella vaccination. A study to determine the etiological diagnosis of exanthema was carried out in a group of children after measles vaccination. METHODS: Sera collected from children with rash who received measles vaccine were reported in 1999. They were analyzed for IgM antibodies against measles virus, rubella virus, human parvovirus B19 (HPV B19) using ELISA commercial techniques, and human herpes virus 6 (HHV 6) using immunofluorescence commercial technique. Viremia for each of those viruses was tested using a polimerase chain reaction (PCR). RESULTS: A total of 17 cases of children with exanthema after measles immunization were reported in 1999. The children, aged 9 to 12 months (median 10 months), had a blood sample taken for laboratory analysis. The time between vaccination and the first rash signs varied from 1 to 60 days. The serological results of those 17 children suspected of measles or rubella infection showed the following etiological diagnosis: 17.6% (3 in 17) HPV B19 infection; 76.5% (13 in 17) HHV 6 infection; 5.9% (1 in 17) rash due to measles vaccine. CONCLUSIONS: The study data indicate that infection due to HPV B19 or HHV 6 can be misdiagnosed as exanthema due to measles vaccination. Therefore, it is important to better characterize the etiology of rash in order to avoid attributing it incorrectly to measles vaccine. OBJETIVO: O diagnóstico diferencial de doenças exantemáticas causadas por vírus é geralmente difícil, e equívocos não são raros, especialmente depois da introdução da vacina contra o sarampo e a rubéola. Um estudo laboratorial foi conduzido com o objetivo de estabelecer o diagnóstico etiológico de casos de exantema em crianças que receberam a vacina contra o sarampo. MÉTODOS: Soros de casos de exantema em crianças que receberam vacina contra o sarampo, em 1999, foram analisados para anticorpos IgM contra os vírus do sarampo, da rubéola e do parvovírus humano B19 (HPV B19), por técnicas comerciais de Elisa, e o herpes vírus humano tipo 6 (HHV 6), por técnica comercial de imunofluorecência. A viremia para cada um desses vírus foi testada pela reação em cadeia da polimerase (PCR). RESULTADOS: Foram notificados, em 1999, 17 casos de crianças com exantema pós-vacinal. A idade das crianças era de nove a 12 meses (mediana, dez meses). Uma amostra de sangue colhida para investigação laboratorial foi obtida para cada criança. O tempo decorrido entre a aplicação da vacina e o aparecimento do exantema variou de um a 60 dias. Os resultados da sorologia das 17 crianças sugeriram o seguinte diagnóstico etiológico para o exantema: 17,6% (três em 17) infecção pelo HPV B19; 76,5% (13 em 17) infecção pelo HHV 6; 5,9% (um em 17) exantema originado pela vacina do sarampo. CONCLUSÃO: Os resultados indicaram que a infecção pelo HPV B19 ou pelo HHV 6 pode ser diagnosticada como sarampo de origem vacinal. Portanto, é fundamental incluir esses vírus no diagnóstico laboratorial para corretamente apontar a etiologia das doenças exantemáticas, evitando, assim, atribuir à vacina do sarampo efeito colateral. Universidade de São Paulo. Faculdade de Saúde Pública2002-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rsp/article/view/2531710.1590/S0034-89102002000200006Revista de Saúde Pública; Vol. 36 No. 2 (2002); 155-159 Revista de Saúde Pública; Vol. 36 Núm. 2 (2002); 155-159 Revista de Saúde Pública; v. 36 n. 2 (2002); 155-159 1518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/rsp/article/view/25317/27062Copyright (c) 2017 Revista de Saúde Públicainfo:eu-repo/semantics/openAccessOliveira, Maria ICurti, Suely PFigueiredo, Cristina AAfonso, Ana MSTheobaldo, MárciaAzevedo, Raymundo SDurigon, Edison L2012-05-29T19:22:35Zoai:revistas.usp.br:article/25317Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2012-05-29T19:22:35Revista de Saúde Pública - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
Exantema após vacinação do sarampo: análise laboratorial de casos notificados em São Paulo
title Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
spellingShingle Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
Oliveira, Maria I
Vacinação do sarampo
Parvovírus humano B19
Herpes vírus humano 6
Exantema
Rubéola
Sarampo
Measles vaccination
Human parvovirus B19
Human herpes virus 6
Exanthema
Rubella
Measles
Oliveira, Maria I
Vacinação do sarampo
Parvovírus humano B19
Herpes vírus humano 6
Exantema
Rubéola
Sarampo
Measles vaccination
Human parvovirus B19
Human herpes virus 6
Exanthema
Rubella
Measles
title_short Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
title_full Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
title_fullStr Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
title_full_unstemmed Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
title_sort Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil
author Oliveira, Maria I
author_facet Oliveira, Maria I
Oliveira, Maria I
Curti, Suely P
Figueiredo, Cristina A
Afonso, Ana MS
Theobaldo, Márcia
Azevedo, Raymundo S
Durigon, Edison L
Curti, Suely P
Figueiredo, Cristina A
Afonso, Ana MS
Theobaldo, Márcia
Azevedo, Raymundo S
Durigon, Edison L
author_role author
author2 Curti, Suely P
Figueiredo, Cristina A
Afonso, Ana MS
Theobaldo, Márcia
Azevedo, Raymundo S
Durigon, Edison L
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Oliveira, Maria I
Curti, Suely P
Figueiredo, Cristina A
Afonso, Ana MS
Theobaldo, Márcia
Azevedo, Raymundo S
Durigon, Edison L
dc.subject.por.fl_str_mv Vacinação do sarampo
Parvovírus humano B19
Herpes vírus humano 6
Exantema
Rubéola
Sarampo
Measles vaccination
Human parvovirus B19
Human herpes virus 6
Exanthema
Rubella
Measles
topic Vacinação do sarampo
Parvovírus humano B19
Herpes vírus humano 6
Exantema
Rubéola
Sarampo
Measles vaccination
Human parvovirus B19
Human herpes virus 6
Exanthema
Rubella
Measles
description OBJECTIVE: The clinical differential diagnosis of rash due to viral infections is often difficult, and misdiagnosis is not rare, especially after the introduction of measles and rubella vaccination. A study to determine the etiological diagnosis of exanthema was carried out in a group of children after measles vaccination. METHODS: Sera collected from children with rash who received measles vaccine were reported in 1999. They were analyzed for IgM antibodies against measles virus, rubella virus, human parvovirus B19 (HPV B19) using ELISA commercial techniques, and human herpes virus 6 (HHV 6) using immunofluorescence commercial technique. Viremia for each of those viruses was tested using a polimerase chain reaction (PCR). RESULTS: A total of 17 cases of children with exanthema after measles immunization were reported in 1999. The children, aged 9 to 12 months (median 10 months), had a blood sample taken for laboratory analysis. The time between vaccination and the first rash signs varied from 1 to 60 days. The serological results of those 17 children suspected of measles or rubella infection showed the following etiological diagnosis: 17.6% (3 in 17) HPV B19 infection; 76.5% (13 in 17) HHV 6 infection; 5.9% (1 in 17) rash due to measles vaccine. CONCLUSIONS: The study data indicate that infection due to HPV B19 or HHV 6 can be misdiagnosed as exanthema due to measles vaccination. Therefore, it is important to better characterize the etiology of rash in order to avoid attributing it incorrectly to measles vaccine.
publishDate 2002
dc.date.none.fl_str_mv 2002-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rsp/article/view/25317
10.1590/S0034-89102002000200006
url https://www.revistas.usp.br/rsp/article/view/25317
identifier_str_mv 10.1590/S0034-89102002000200006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rsp/article/view/25317/27062
dc.rights.driver.fl_str_mv Copyright (c) 2017 Revista de Saúde Pública
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2017 Revista de Saúde Pública
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Saúde Pública
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Saúde Pública
dc.source.none.fl_str_mv Revista de Saúde Pública; Vol. 36 No. 2 (2002); 155-159
Revista de Saúde Pública; Vol. 36 Núm. 2 (2002); 155-159
Revista de Saúde Pública; v. 36 n. 2 (2002); 155-159
1518-8787
0034-8910
reponame:Revista de Saúde Pública
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Revista de Saúde Pública
collection Revista de Saúde Pública
repository.name.fl_str_mv Revista de Saúde Pública - Universidade de São Paulo (USP)
repository.mail.fl_str_mv revsp@org.usp.br||revsp1@usp.br
_version_ 1822179092177354752
dc.identifier.doi.none.fl_str_mv 10.1590/S0034-89102002000200006